| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), QURE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 540.3K | $10.48M | - | |
| CFO | 226.6K | $2.05M | - | |
| Other | 133.2K | $3.69M | - | |
| Other | 108.9K | $2.95M | - | |
| Other | 50.5K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Klemt Christian58 | Chief Financial Officer | Sell | 17,257 | $10.80 | $186,457.82 | -10.0% | +24.6% | +29.1% | |
| Dec 10, 2024 | Kapusta Matthew C64 | CEO, Managing Director | Sale+OE | 100,000 | $15.03 | $1,503,000.00 | -14.3% | -23.5% | +31.6% | |
| Dec 9, 2024 | Kapusta Matthew C64 | CEO, Managing Director | Sell | 3,418 | $7.63 | $26,079.34 | -0.6% | +60.4% | +184.9% | |
| Dec 9, 2024 | Klemt Christian58 | Chief Financial Officer | Sell | 1,796 | $7.55 | $13,559.80 | -1.1% | +60.4% | +184.9% | |
| Jun 26, 2024 | Abi-Saab Walid | Chief Medical Officer | Sell | 1,447 | $4.36 | $6,308.92 | -1.2% | +16.8% | +223.4% | |
| Jun 17, 2024 | Caloz Pierre64 | Chief Operating Officer | Sell | 2,936 | $4.81 | $14,122.16 | -2.5% | +15.4% | +215.4% | |
| Jun 17, 2024 | Klemt Christian58 | Chief Financial Officer | Sell | 1,611 | $4.80 | $7,732.80 | -1.0% | +15.4% | +215.4% | |
| Jun 13, 2024 | Potts Jeannette | Chief Legal Officer | Sell | 4,781 | $4.98 | $23,809.38 | -4.9% | +4.2% | +192.2% | |
| Jun 13, 2024 | Jacques Rachelle Suzanne45 | Director | Sell | 2,221 | $5.14 | $11,415.94 | -13.4% | +4.2% | +192.2% | |
| Jun 13, 2024 | Kaye Jack48 | Director | Sell | 2,218 | $5.16 | $11,444.88 | -25.4% | +4.2% | +192.2% |